VistaGen Therapeutics (VTGN) 2025 Conference June 05, 2025 11:40 AM ET Speaker0 All right, we're going to get started with our next session. I'm Andrew Tsai, senior biotech analyst at Jefferies. Thanks for tuning in and it's my pleasure to have Sean Singh, CEO of Vistagen joining me today. Welcome Sean. Speaker1 Thanks Andrew. Great to see you again. Speaker0 Great. So maybe a brief introduction about Vistagen, what you're working on and what you're trying to achieve and milestones over the next six to twel ...